Skip to main content
You can use boolean operators like AND, OR and NOT (in capital letters) to narrow your search.
ref document icon

56th Rapid Exchange Forum: Ethical, Legal and Social Issues (ELSI) on Health Data Processing

Question

Ethical, Legal and Social Issues (ELSI) on Health Data Processing

  • Are there any best practices or specific limitations? 
  • Are there efforts for more coherent ELSI principles?
  • Which enablers or which barriers do you experience?
  • Current changes in legislation (e.g. in light of upcoming EHDS regulation)?
Date
25-Sep-2023
File
56_REF_minutes_questions.pdf
ref document icon

58th Rapid Exchange Forum: Covid-19 measures – Update per October 2023

Question

Covid-19 measures – Update per October 2023

The following Y/N questions, asked in a live poll during the meeting, are intended to be displayed on the Health Information Portal:

A. Vaccination

1. Is Covid-19 vaccination for free in your country?

2. Is a booster vaccination free in your country?

3. Is Covid-19 vaccination or booster available in pharmacies?

4. Do you have a vaccination strategy / recommendation for children below 12 years?

B. Surveillance

5. Is there a Long-Covid strategy in place in your country?

6. Does your country have a registry on Long-Covid patients?

7. Is there a wastewater monitoring in your country or at least regionally?

8. Is there a national Covid-19 dashboard that is currently being serviced?

C. Measures

9. Are there actually any measures or restrictions in place?

10. Is self-testing for free in your country?

11. Is it possible to book a test-slot for free in your country?

12. Is it possible to book a test-slot against payment in your country?

13. Is it mandatory to wear face masks in hospital settings?

14. Is an evaluation of the pandemic measures in your country planned or already ongoing?

15. Can the pandemic response team be reactivated any time quickly (within 2 days)?

Date
23-Oct-2023
File
58_REF_minutes_questions_update_20231030.pdf
ref document icon

Rapid Exchange Forum - Special Edition 6th

Question

Harmonising advances in Long COVID research: Uniting European actors for solutions

Date
09-Oct-2023
File
Minutes_Presentations_Merged.pdf
Free keywords
ref document icon

25th Rapid Exchange Forum: COVID-19 vaccinations for children

Question

Covid-19 vaccinations for children

In the light of the recent EMA decision:

  • Do you currently have a specific vaccination strategy for children below 12 years? Yes/No
  • If yes, please share further information.
  • If yes, to what extent schools, school doctors and nurses will provide Covid-19 vaccinations for children?
Date
06-Dec-2021
File
25_REF_minutes_questions.pdf
ref document icon

26th Rapid Exchange Forum: Omicron variant

Question

OMICRON - SARS CoV 2 B.1.1.529 variant of concern

  • What is the state of play regarding the recent VOC 'Omicron' in your country?
  • Has your country implemented new/adapted measures specifically to address the threat posed by the spread of the Omicron variant? (Or are such measures planned?)
Date
20-Dec-2021
File
26_REF_minutes_questions.pdf
ref document icon

59th Rapid Exchange Forum: Covid-19 combined vaccination

Question

Covid-19 combined vaccination

In countries where Covid-19 is vaccinated combined with another immunization, e.g. against influenza, was there a (remarkable) increase of Covid-19 vaccinations? What could have caused this increase, what are the possible reasons? Are there any learnings with such a system? Please share your experiences.

Date
20-Nov-2023
File
59_REF_minutes_questions.pdf
ref document icon

61st Rapid Exchange Forum: Human Respiratory Syncytial Virus (RSV) and hospitalisation rate in children

Question

Human Respiratory Syncytial Virus (RSV) and hospitalisation rate in children

Date
15-Jan-2024
File
61_REF_minutes_questions.pdf
ref document icon

Rapid Exchange Forum ad-hoc question (Austria): Prevalence of sexually transmitted infections in Europe

Question

Prevalence of sexually transmitted infections in Europe

Currently there is a systematic review conducted on the prevalence of 4 sexually transmitted infections in Europe: chlamydia, gonorrhoea, syphilis and trichomoniasis. We are conducting extensive literature searches in bibliographic databases but are also interested in grey literature. We would be very grateful if you could:

  • indicate to us any reports on the prevalence of any of the 4 STIs in your country, published/conducted within the last 10 years, that has not been published in a peer-reviewed journal
  • and/or forward our request to experts in the field in your country!

(The focus of this request is on grey literature, but please don’t hesitate to also indicate relevant peer-reviewed literature, especially recent publications.)

Please note that for this review we are not interested in incidence estimates derived from routine surveillance (i.e., number of case notifications per national/regional population), but only in prevalence estimates derived from a study where the total population of tested individuals is known and described.

Date
18-Dec-2023
File
REF_ad-hoc question_prevalence of sexually transmitted infections.pdf
ref document icon

62nd Rapid Exchange Forum: Covid infection in vaccinated people in autumn/winter

Question

Covid infection in vaccinated people in autumn/winter

Date
12-Feb-2024
File
62_REF_minutes_questions.pdf
4_REF on population health_thematic input.pdf
ref document icon

63rd Rapid Exchange Forum: Trust in exchange of data for secondary use purposes

Question

Trust in exchange of data for secondary use purposes

Date
11-Mar-2024
File
63_REF_minutes_questions.pdf
5_REF on population health_thematic input.pdf